Ibogaine treatment is accessible in Canada. Ibogaine is not listed under the Controlled Drugs and Substances Act — the legislation that schedules cocaine, heroin, and psilocybin. Getting ibogaine treatment involves a specific sequence: medical screening that may disqualify you before ceremony is confirmed, an intake process, a 12–24 hour active experience, and an integration period that determines whether anything lasting comes from it. The medicine is not appropriate for everyone. The people for whom it is not appropriate are not a small category.
To get ibogaine treatment in Canada: submit an application to a provider, complete a full medical screening — EKG, blood panel, medication review, and psychiatric assessment — receive clearance, prepare for 2–3 days on-site, attend ceremony, and commit to integration support in the weeks that follow. Ibogaine is not listed under Canada's Controlled Drugs and Substances Act. In the United States, it is Schedule I. Most Americans access treatment by travelling to Mexico or Canada.
Where Ibogaine Treatment Is Available
The legal situation differs by country — and that distinction determines practically where you can access treatment.
United States. Ibogaine has been Schedule I under the Controlled Substances Act since 1970, before any US clinical research on the compound had been conducted. There is no licensed clinical provision in the US outside registered research trials. People seeking ibogaine treatment from the US almost always travel internationally.
Canada. Ibogaine is not listed under Canada's Controlled Drugs and Substances Act — a distinct legal position from the US and from the classification of psilocybin or cocaine under Canadian federal law. Providers operating in British Columbia, including ExploreBwiti in Vancouver, do so within this framework. This is not a loophole. It is the law as written.
Mexico.Mexico is where most Americans travel for ibogaine treatment. Established providers operate legally. Quality varies enormously — from physician-supervised centres with cardiac monitoring to operations that lack the medical infrastructure to manage an adverse event. Legal status in the provider's jurisdiction is not a safety certification.
Other countries. Ibogaine is available in Portugal, the Netherlands, Costa Rica, New Zealand, and several other jurisdictions where it is either unscheduled or accessible through specific regulatory pathways. The landscape shifts; verify the current status independently before you travel.
Legal status is a practical consideration. It is not the primary criterion for choosing a provider. Whether the provider has adequate medical infrastructure — an on-site medical professional for the full 12–24 hour ceremony, cardiac monitoring equipment, and the protocols to manage an emergency — is the criterion that matters.
What Medical Screening Involves
Medical screening for ibogaine is not optional. It is how a provider identifies whether the medicine is safe for you specifically. Any provider that does not require it is not operating safely — they are reducing safety infrastructure to reduce costs.
EKG and cardiovascular assessment. Ibogaine prolongs the QT interval — a measurable property of cardiac electrical rhythm. QT prolongation at baseline, or the presence of significant cardiac arrhythmia, is an absolute contraindication. The EKG identifies this before ceremony. Without one, there is no way to know.
Blood panel. Full metabolic panel covering liver function, kidney function, and a complete blood count. Ibogaine is metabolised hepatically. Severe liver disease is a contraindication. Electrolyte abnormalities affect cardiac risk independently.
Medication review. This is the step most frequently skipped at unsafe providers. SSRIs, SNRIs, lithium, methadone, and several other medications interact with ibogaine in ways that carry serious or fatal risk. SSRIs and SNRIs are absolute contraindications due to the risk of serotonin syndrome. This is not a preference — there are no exceptions. Continuing an SSRI through ibogaine ceremony is not a calculated risk. It is the absence of appropriate screening.
Psychiatric history assessment. Active psychosis and schizophrenia-spectrum disorders are absolute contraindications. People in states of acute psychiatric crisis are not appropriate candidates, regardless of how urgently they want access.
Full medical history review. Prior hospitalisations, diagnoses, family history of cardiac conditions, and prior substance use history are all relevant. The 2023 Stanford study — published in Nature Medicine — found an average 88% reduction in PTSD symptoms and 87% reduction in depression symptoms at one month in 30 treatment-resistant veterans. Every one of those participants was screened thoroughly before the treatment began. That context was not incidental to the outcome.
The Application and Intake Process
The process at a reputable provider follows a consistent sequence. It is not designed to create obstacles. It is designed to identify whether the conversation should proceed — and what preparation is required if it does.
Step 1 — Initial application. Most providers begin with a written intake form covering health history, current medications, what you are seeking treatment for, and what approaches you have tried previously. This establishes whether there are obvious disqualifiers before either party invests further time.
Step 2 — Intake conversation. If the written application passes basic review, you will speak with the provider. At ExploreBwiti, this is a personal response — not a form acknowledgement. The conversation covers your history in depth, your motivations, your support structure, and what integration support looks like after ceremony. It typically runs 60–90 minutes.
Step 3 — Medical screening.You obtain an EKG and bloodwork — either through your GP or through the provider's medical team. Results are reviewed by the on-site medical professional before ceremony is confirmed. If something disqualifying is found, you are told directly.
Step 4 — Preparation. Once cleared, preparation begins: dietary adjustments, medication tapers where required (coordinated with your prescribing physician — not an improvised process), and logistical arrangements for the 2–3 days on-site. The ceremony page covers what to expect during that time.
The intake process at a provider worth trusting is thorough enough to screen people out. The conversation that ends in a “no” is not a failure of the process. It is the process working correctly. If you are not an appropriate candidate, a responsible provider says so directly — and does not soften it.
What Ibogaine Treatment Costs
In Canada, ibogaine ceremony costs range from $2,000 to $5,000 CAD. This includes the on-site medical professional, the medicine, and facilitation. Integration coaching is separate — $150–$300 CAD per session, with packages of three or more sessions available.
In Mexico, costs generally run higher in USD terms: typically $5,000–$10,000 or more, depending on facility quality and length of stay. Most programmes bundle accommodation into that figure.
What the price reflects: an ibogaine ceremony requires an on-site medical professional, cardiac monitoring equipment, pharmaceutical-grade or ceremonially-sourced medicine, pre-screening, and trained facilitation across a 12–24 hour experience. None of these components are optional. They have real costs.
Any provider charging significantly below these ranges is not being generous. They are missing something. The cost of on-site medical staff, proper screening, and the medicine itself is real. A $500 ibogaine ceremony does not include any of this. The fatalities that have occurred in ibogaine treatment are concentrated among providers who skipped cardiac screening — not among those who charged more than someone hoped to pay.
No insurance covers ibogaine treatment in Canada or the United States at this time. It is a direct out-of-pocket expense. For people who have a long treatment history behind them — years of SSRIs that managed but did not resolve, residential programmes that held and then did not — the comparison is not a single cost versus nothing.
Who This Is Not For
Ibogaine is not appropriate for a significant number of people who seek it. Being direct about this is not a sales deterrent. It is the minimum a responsible provider owes the person asking.
Absolute contraindications:
- QT prolongation, significant cardiac arrhythmia, or recent myocardial infarction. Ibogaine prolongs the QT interval. EKG screening before ceremony is the only way to identify this risk. Without it, you do not know.
- Current SSRIs or SNRIs. The risk of serotonin syndrome is real and potentially fatal. A supervised taper — conducted with your prescribing physician — is required before ceremony is possible. Not a few days without medication. A supervised taper. There are no exceptions, and any provider who suggests otherwise is not operating safely.
- Methadone. A specific supervised transition protocol is required. This cannot be improvised or abbreviated.
- Lithium and certain other psychiatric medications. The interaction risks are documented and not negotiable.
- Active psychosis or schizophrenia-spectrum disorder.
- Severe liver or kidney disease.
- Pregnancy.
Beyond the medical contraindications, ibogaine is not appropriate for people in acute psychiatric crisis — regardless of how urgently they want it. The medicine amplifies what is present. Crisis does not resolve inside ibogaine ceremony. It becomes more acute.
It is also not the right medicine for people who are primarily seeking an experience. The medicine tends to show people what they have been avoiding, not what they came to find. People who arrive expecting an expansive or clarifying altered state are consistently surprised by how direct iboga is. That is not a failure of the ceremony. It is the ceremony working as intended.
The people who tend to produce the best outcomes are those who arrive having already tried other things. SSRIs that managed but did not resolve. Abstinence programmes that held for months and then did not. Therapy that circled without landing. By the time they arrive, they are not naive about the difficulty of what they are attempting — and that scepticism tends to produce genuine readiness for what the medicine shows them.
If you are not an appropriate candidate, we will say so directly and without softening it. The FAQ covers the full contraindication list and what happens when someone does not pass screening.
Is This Right for You?
No application guarantees access. Screening may determine that a medication taper needs to happen first, that cardiac conditions need further evaluation, or that a different kind of support is the more appropriate starting point. These are not rejections. They are the intake process giving you accurate information.
If you are currently on SSRIs or SNRIs, the conversation starts with your prescribing physician and a supervised taper. That taper is a prerequisite to ceremony. The timeline varies by medication — some require weeks, others months. This step cannot be skipped or abbreviated.
Ceremony at ExploreBwiti in Vancouver costs $2,000–$5,000 CAD, including the on-site medical professional, medicine, and facilitation. Integration coaching runs $150–$300 per session. Both are components of the same process — the ceremony opens a window; integration is the work done while it is open.
The FAQ covers screening, contraindications, and what the first conversation looks like. The full current list of registered ibogaine clinical trials is on ClinicalTrials.gov for those who want to review the research landscape before deciding. When you are ready to begin, the application is where it starts — we respond personally to every application within 2–3 business days.